<?xml version='1.0' encoding='utf-8'?>
<document id="30516093"><sentence text="Application of unbound liver-to-plasma concentration ratio to quantitative projection of cytochrome P450-mediated drug-drug interactions using physiologically based pharmacokinetic modelling approach." /><sentence text="1" /><sentence text=" This study evaluated the prediction accuracy of cytochrome P450 (CYP)-mediated drug-drug interaction (DDI) using minimal physiologically-based pharmacokinetic (PBPK) modelling incorporating the hepatic accumulation factor of an inhibitor (i" /><sentence text="e" /><sentence text=" unbound liver/unbound plasma concentration ratio [Kp,uu,liver]) based on 22 clinical DDI studies" /><sentence text=" 2" /><sentence text=" Kp,uu,liver values were estimated using three methods: (1) ratio of cell-to-medium ratio in human cryopreserved hepatocytes (C/Mu) at 37 °C to that on ice (Kp,uu,C/M), (2) multiplication of total liver/unbound plasma concentration ratio (Kp,u,liver) estimated from C/Mu at 37 °C with unbound fraction in human liver homogenate (Kp,uu,cell) and (3) observed Kp,uu,liver in rats after intravenous infusion (Kp,uu,rat)" /><sentence text=" 3" /><sentence text=" PBPK model using each Kp,uu,liver projected the area under the curve (AUC) increase of substrates more accurately than the model assuming a Kp,uu,liver of 1 for the average fold error and root mean square error did" /><sentence text=" Particularly, the model with a Kp,uu,liver of 1 underestimated the AUC increase of triazolam following co-administration with CYP3A4 inhibitor itraconazole by five-fold, whereas the AUC increase projected using the model incorporating the Kp,uu,C/M, Kp,uu,cell, or Kp,uu,rat of itraconazole and hydroxyitraconazole was within approximately two-fold of the actual value"><entity charOffset="84-93" id="DDI-PubMed.30516093.s10.e0" text="triazolam" /><entity charOffset="144-156" id="DDI-PubMed.30516093.s10.e1" text="itraconazole" /><entity charOffset="279-291" id="DDI-PubMed.30516093.s10.e2" text="itraconazole" /><entity charOffset="296-315" id="DDI-PubMed.30516093.s10.e3" text="hydroxyitraconazole" /><pair ddi="false" e1="DDI-PubMed.30516093.s10.e0" e2="DDI-PubMed.30516093.s10.e0" /><pair ddi="false" e1="DDI-PubMed.30516093.s10.e0" e2="DDI-PubMed.30516093.s10.e1" /><pair ddi="false" e1="DDI-PubMed.30516093.s10.e0" e2="DDI-PubMed.30516093.s10.e2" /><pair ddi="false" e1="DDI-PubMed.30516093.s10.e0" e2="DDI-PubMed.30516093.s10.e3" /><pair ddi="false" e1="DDI-PubMed.30516093.s10.e1" e2="DDI-PubMed.30516093.s10.e1" /><pair ddi="false" e1="DDI-PubMed.30516093.s10.e1" e2="DDI-PubMed.30516093.s10.e2" /><pair ddi="false" e1="DDI-PubMed.30516093.s10.e1" e2="DDI-PubMed.30516093.s10.e3" /><pair ddi="false" e1="DDI-PubMed.30516093.s10.e2" e2="DDI-PubMed.30516093.s10.e2" /><pair ddi="false" e1="DDI-PubMed.30516093.s10.e2" e2="DDI-PubMed.30516093.s10.e3" /></sentence><sentence text=" 4" /><sentence text=" The results indicated that incorporating Kp,uu,liver into the PBPK model improved the accuracy of DDI projection" /><sentence text="" /></document>